Issue Detection and Escalation in Clinical Trial Settings

Speaker

Instructor: John (Jack) McLane 
Product ID: 702261

Location
  • Duration: 60 Min
This webinar on issue detection and escalation in clinical trial settings will review the responsibilities of sponsors, investigators, IRB, vendors and CROs in clinical trial setting to maintain compliance. We will discuss how you can proactively monitor to prevent issues and in case of issue detection, escalate them.
RECORDED TRAINING
Last Recorded Date: Jun-2012

 

$229.00
1 Person Unlimited viewing for 6 month info Recorded Link and Ref. material will be available in My CO Section
(For multiple locations contact Customer Care)

$299.00
Downloadable file is for usage in one location only. info Downloadable link along with the materials will be emailed within 2 business days
(For multiple locations contact Customer Care)

 

 

Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

 

Why Should You Attend:

In recent years the FDA has increased the number of clinical sites and trials that have been inspected and audited.  The number of investigators under investigation or disqualified has increased.  IRBs have been inspected and issued with 483 letters.

What would happen: If the site enrolls some subjects that don't meet all the entry criteria? Have unreported safety issues?  Don't sign the CRF? Are not accurate in reporting the data?  Don't follow their own SOP?  Are these issues hidden in your monitoring reports or not there at all?   The FDA does conduct audits of the sites and will issue 483 letters to either the sites or to sponsors.   During a market review of data submitted for example an NDA they can disqualify the data if not consistent, they  can disqualify a site if they have had protocol, GCP or SOP deviations.  They can disqualify a whole study or application if the issues are systemic.  Do you have the processes to assure compliance?

This webinar will help you understand the responsibilities of sponsors, investigators, IRB, vendors and CROs in clinical trial setting to maintain compliance. We will discuss how you can proactively monitor to prevent issues and in case of issue detection, escalate them.

Areas Covered in the Seminar:

  • Checking the investigators and IRB qualifications and training.
  • Preventive risk mitigation methods including training and monitoring sites.
  • Considerations for protocol violations.
  • Issuing protocol deviations.
  • Communication plans with issue escalations and contingency planning.
  • Monitor report templates.
  • Process maps for risk mitigations and action items including escalation.

Learning Objectives:

  • Understanding of  responsibilities of sponsors, investigators, IRB, vendors and CROs in clinical trial setting to maintain compliance.
  • Proactive monitoring to prevent issues.
  • Project managing risk mitigation.
  • Contingency planning.
  • Issue escalation.

Who will Benefit:

This webinar will provide valuable assistance and procedures for sponsors, clinical site managers, CROs, and clinical trial vendors (central labs, drug supply imaging service companies). The following individuals would benefit from this webinar:

  • Clinical operations
  • Project managers
  • Clinical Research Associates (CRA)
  • Clinical Trial Associates (CTA)
  • Medical monitors
  • Pharmacovigilance specialists
  • Site managers
  • Principle Investigators

Instructor Profile:

John (Jack) McLane, Ph.D. COO and VP of Clinical and Regulatory Affairs at Clinquest, Inc. has over 25 years of experience in the pharmaceutical and medical device with both large and small pharmaceuticals and CRO. He has been directly involved in over 100 clinical studies, filed numerous INDs/ IDEs and three NDA/MAA submissions. As a leader in risk assessments and mitigations he understands and implements processes in complex teams to evaluate means to reduce risks from occurring and if they occur how they will be handled.

Follow us :

 

 

Refund Policy

Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).

 

 

+1-888-717-2436

6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube

 

Copyright © 2023 ComplianceOnline.com MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method